首页|积雪草酸对去卵巢骨质疏松大鼠骨质疏松的改善作用

积雪草酸对去卵巢骨质疏松大鼠骨质疏松的改善作用

扫码查看
目的 探讨积雪草酸对骨保护素(OPG)/核因子-κB受体活化因子配体(RANKL)信号通路的影响及其对去卵巢骨质疏松大鼠骨质疏松的改善作用。方法 雌性SD大鼠40只,体质量200~220 g,随机分为假手术组、模型组、积雪草酸组、雌二醇组各10只。模型组、积雪草酸组、雌二醇组大鼠采用卵巢切除法制备骨质疏松模型,假手术组仅打开腹腔,不切除卵巢;造模成功后积雪草酸组大鼠灌胃积雪草酸混悬液120 mg/kg,雌二醇组大鼠灌胃雌二醇片混悬液0。184 mg/kg,假手术组和模型组大鼠灌胃等量生理盐水,均1次/d,连续12周。测量各组大鼠左侧股骨近端骨密度(BMD),采用ELISA法检测血清雌二醇、骨形成标志物[骨钙素(BGP)、Ⅰ型前胶原氨基端原肽(PⅠ NP)]、骨吸收标志物[Ⅰ型胶原C端肽(CTX-Ⅰ)、抗酒石酸酸性磷酸酶5b(TRAP-5b)]水平,行micro-CT检查测量右侧股骨骨体积分数(BV/TV)、骨小梁数量(Tb。N)、骨小梁厚度(Tb。Th),采用三点弯曲法测量右侧股骨生物力学,采用Western blot法检测右侧股骨组织OPG、RANKL、核因子-κB受体活化因子(RANK)蛋白相对表达量。结果 药物干预前、后,4组左侧股骨BMD及血清雌二醇水平比较差异均有统计学意义(F=31。570~63。726,P均<0。05);药物干预后,假手术组、雌二醇组、积雪草酸组、模型组左侧股骨 BMD[(241。95±27。35)、(210。77±19。63)、(173。49±18。54)、(108。32±24。43)g/cm2]及血清雌二醇水平[(475。93±84。50)、(395。67±52。83)、(321。88±46。42)、(215。37±31。05)ng/L]均依次降低(P<0。05),积雪草酸组、雌二醇组均高于药物干预前(P<0。05),假手术组、模型组与药物干预前比较差异均无统计学意义(P>0。05)。4组血清BGP、PⅠ NP、TRAP-5b、CTX-Ⅰ水平,右侧股骨BV/TV、Tb。N、Tb。Th、最大载荷、断裂挠度及RANKL、RANK、OPG蛋白相对表达量比较差异均有统计学意义(F=14。556~332。330,P均<0。05);假手术组血清 BGP[(4。95±0。34)ng/L]、PⅠ NP[(33。99±4。21)μg/L]水平及右侧股骨 BV/TV[(0。29±0。03)%]、Tb。N[(1。85±0。25)个]、Tb。Th[(0。15±0。04)mm]、最大载荷[(138。44±11。05)N]、断裂挠度[(220。47±14。95)N/mm]及 OPG蛋白相对表达量(0。88±0。05)均高于模型组[(2。04±0。21)ng/L、(13。50±2。53)μg/L、(0。11±0。02)%、(1。02±0。16)个、(0。07±0。01)mm、(71。35±9。21)N、(137。96±16。82)N/mm、0。32±0。05]、积雪草酸组[(2。97±0。59)ng/L、(24。67±2。10)μg/L、(0。20±0。02)%、(1。60±0。16)个、(0。11±0。03)mm、(118。48±9。46)N、(183。46±15。13)N/mm、0。78±0。06]、雌二醇组[(3。18±0。53)ng/L、(26。82±2。53)μg/L、(0。22±0。04)%、(1。65±0。14)个、(0。12±0。02)mm、(122。07±11。25)N、(194。75±15。76)N/mm、0。79±0。07](P<0。05),积雪草酸组、雌二醇组均高于模型组(P<0。05);假手术组血清 CTX-Ⅰ[(75。93±8。42)ng/L]、TRAP-5b[(11。84±3。46)μg/L]水平及右侧股骨组织 RANK、RANKL 蛋白相对表达量(0。23±0。04、0。26±0。03)均低于模型组[(147。24±11。30)ng/L、(30。51±5。22)μg/L、0。91±0。06、0。87±0。06]、积雪草酸组[(112。83±6。22)ng/L、(21。76±3。42)μg/L、0。54±0。04、0。61±0。05]、雌二醇组[(108。35±7。17)ng/L、(19。86±3。08)μg/L、0。56±0。05、0。63±0。06](P<0。05),积雪草酸组、雌二醇组均低于模型组(P<0。05);以上指标积雪草酸组与雌二醇组比较差异均无统计学意义(P>0。05)。结论 积雪草酸可提高骨质疏松大鼠骨密度,修复骨小梁微结构,改善骨代谢,可能与其调节OPG/RANKL信号通路有关。
Role of asiatic acid in treating osteoporosis in ovariectomized osteoporotic rats
Objective To investigate the influence of asiatic acid on osteoprotegerin(OPG)/receptor activator of nuclear factor-κB ligand(RANKL)signaling pathway and its role in treating osteoporosis in ovariectomized osteoporotic rats.Methods Forty female SD rats,weighing 200-220 g,were randomly divided into the sham-surgery group,model group,asiatic acid group and estradiol group,with 10 rats in each group.The osteoporosis models were established in the model group,asiatic acid group and estradiol group by ovariectomy.The rats in the sham-surgery group only had the abdominal cavities opened without removing the ovaries.After successful modeling,the rats in the asiatic acid group received gavage with 120 mg/kg asiatic acid suspension,the rats in the estradiol group received gavage with 0.184 mg/kg estradiol tablet suspension,and the rats in the sham-surgery group and model group received gavage with the same amount of normal saline,once a day for 12 weeks.The bone mineral density(BMD)of the left proximal femur was measured in each group.ELISA was used to detect the serum levels of estradiol,bone formation markers[bone gamma-carboxyglutamic acid protein(BGP),procollagen type Ⅰ N-terminal propeptide(P Ⅰ NP)],and bone resorption markers[C-telopeptide of type Ⅰ collagen(CTX-Ⅰ),tartrate-resistant acid phosphatase-5b(TRAP-5b)].Micro-CT scan was done to measure the right femur bone volume fraction(BV/TV),trabecular number(Tb.N)and trabecular thickness(Tb.Th);three-point bending method was used to measure the biomechanics;Western blot was used to detect the relative expressions of OPG,RANKL and receptor activator of nuclear factor-κB(RANK)proteins.Results Before and after drug intervention,the left femur BMDs and serum estradiol levels showed significant differences among four groups(F=31.570-63.726,all P values<0.05).After drug intervention,the BMDs[(241.95±27.35),(210.77±19.63),(173.49±18.54),(108.32±24.43)g/cm2]and serum estradiol levels[(475.93±84.50),(395.67±52.83),(321.88±46.42),(215.37±31.05)ng/L]decreased sequentially in the sham-surgery group,estradiol group,asiatic acid group and model group(P<0.05),were higher than those before drug intervention in the asiatic acid group and estradiol group(P<0.05),and showed no significant differences in the sham-surgery group and model group compared with those before drug intervention(P>0.05).The serum levels of BGP,P Ⅰ NP,TRAP-5b and CTX-Ⅰ,the BV/TV,Tb.N,Tb.Th,maximum load and fracture deflection,and the relative expressions of RANKL,RANK and OPG proteins showed significant differences among four groups(F=14.556-332.330,all P values<0.05).The serum BGP[(4.95±0.34)ng/L],PⅠ NP[(33.99±4.21)μg/L],BV/TV[(0.29±0.03)%],Tb.N(1.85±0.25),Tb.Th[(0.15±0.04)mm],maximum load[(138.44±11.05)N],fracture deflection[(220.47±14.95)N/mm],and relative expression of OPG protein(0.88±0.05)were higher in the sham-surgery group than those in the model group[(2.04±0.21)ng/L,(13.50±2.53)μg/L,(0.11±0.02)%,1.02±0.16,(0.07±0.01)mm,(71.35±9.21)N,(137.96±16.82)N/mm,0.32±0.05],asiatic acid group[(2.97±0.59)ng/L,(24.67±2.10)μg/L,(0.20±0.02)%,1.60±0.16,(0.11±0.03)mm,(118.48±9.46)N,(183.46±15.13)N/mm,0.78±0.06],and estradiol group[(3.18±0.53)ng/L,(26.82±2.53)μg/L,(0.22±0.04)%,1.65±0.14,(0.12±0.02)mm,(122.07±11.25)N,(194.75±15.76)N/mm,0.79±0.07](P<0.05),and were higher in the asiatic acid group and estradiol group than those in the model group(P<0.05).The serum levels of CTX-Ⅰ[(75.93±8.42)ng/L]and TRAP-5b[(11.84±3.46)μg/L],and relative expressions of RANK and RANKL proteins(0.23±0.04,0.26±0.03)were lower in the sham-surgery group than those in the model group[(147.24±11.30)ng/L,(30.51±5.22)μg/L,0.91±0.06,0.87±0.06],asiatic acid group[(112.83±6.22)ng/L,(21.76±3.42)μg/L,0.54±0.04,0.61±0.05],and estradiol group[(108.35±7.17)ng/L,(19.86±3.08)μg/L,0.56±0.05,0.63±0.06](P<0.05),were lower in the asiatic acid group and estradiol group than those in the model group(P<0.05),and showed no significant differences between the asiatic acid group and estradiol group(P>0.05).Conclusion Asiatic acid can increase BMD of osteoporotic rats,repair trabecular microstructure,and improve bone metabolism,possibly by regulating OPG/RANKL signaling pathway.

osteoporosisasiatic acidosteoprotegerin/receptor activator of nuclear factor-κB ligand signaling pathwayovariectomizerats

罗燕宁、洪建仁、余双奇

展开 >

黄石市中心医院湖北理工学院附属医院手足显微外科,湖北黄石 435000

武汉市普仁医院脊柱外科,湖北武汉 430081

骨质疏松 积雪草酸 骨保护素/核因子-κB受体活化因子配体信号通路 去卵巢 大鼠

2024

中华实用诊断与治疗杂志
中华预防医学会 河南省人民医院

中华实用诊断与治疗杂志

CSTPCD
影响因子:1.276
ISSN:1674-3474
年,卷(期):2024.38(12)